FDA Approved Antibody-based Therapeutics
FDA Approved Antibody-based Therapeutics Antibody Target: Antibody Type Indication Company Approval Date Rituxan: Rituximab CD20:Chimeric, IgG1 Cancer Genentech 1997 (US) 1998 (EU) Herceptin: Trastuzumab HER2:Humanized, IgG1 Cancer Genentech/ Roche 1998 (US) 2000 (EU) *Mylotarg: Gemtuzumab ozogamicin CD33:Humanized, IgG4, immunotoxin Cancer Wyeth/Pfizer 2000 (US) Campath: Alem..